Isotechnika Pharma receives National Research Council IRAP funding for NICAM program
Isotechnika Pharma Inc. today announced that it has received funding approval from the National Research Council’s Industrial Research Assistance Program for its Non-Immunosuppressive Cyclosporin Analog Molecules program.
Read more on CNW Group via Yahoo! Finance
